PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.04%
Negative revenue growth while QCOM stands at 2.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.64%
Negative gross profit growth while QCOM is at 1.97%. Joel Greenblatt would examine cost competitiveness or demand decline.
-18.51%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.97%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-19.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.21%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-19.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Reduced diluted shares while QCOM is at 0.09%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
4.88%
Maintaining or increasing dividends while QCOM cut them. John Neff might see a strong edge in shareholder returns.
-0.67%
Negative OCF growth while QCOM is at 53.93%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
75.57%
FCF growth 1.25-1.5x QCOM's 61.51%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
61.04%
10Y revenue/share CAGR at 50-75% of QCOM's 102.86%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
15.12%
5Y revenue/share CAGR under 50% of QCOM's 88.58%. Michael Burry would suspect a significant competitive gap or product weakness.
1.24%
3Y revenue/share CAGR under 50% of QCOM's 4.71%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
91.92%
10Y OCF/share CAGR at 50-75% of QCOM's 148.22%. Martin Whitman might fear a structural deficiency in operational efficiency.
-5.86%
Negative 5Y OCF/share CAGR while QCOM is at 1289.40%. Joel Greenblatt would question the firm’s operational model or cost structure.
-8.36%
Negative 3Y OCF/share CAGR while QCOM stands at 137.87%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
220.89%
Net income/share CAGR above 1.5x QCOM's 51.21% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
16.14%
Below 50% of QCOM's 483.21%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-17.80%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
87.00%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
97.18%
Below 50% of QCOM's 2848.60%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
86.15%
Below 50% of QCOM's 259.58%. Michael Burry suspects a serious short-term disadvantage in building book value.
333.29%
10Y dividend/share CAGR above 1.5x QCOM's 129.78%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
68.41%
5Y dividend/share CAGR above 1.5x QCOM's 30.75%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
27.57%
3Y dividend/share CAGR 1.25-1.5x QCOM's 23.19%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
-9.56%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.33%
We show growth while QCOM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.24%
Asset growth at 50-75% of QCOM's 4.16%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
1.60%
Under 50% of QCOM's 4.31%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
5.05%
We have some new debt while QCOM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-2.34%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.10%
We cut SG&A while QCOM invests at 1.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.